Furthermore, flow cytometry analysis demonstrated that the expression levels of AML-associated immunophenotypic markers (CD33, CD123, and CD11b) in bone marrow naïve cells were markedly downregulated 30 days post-treatment with IONPs+Ara-C. The gene discussed is ITGAM; the disease is acute myeloid leukemia.